Skip to search formSkip to main contentSkip to account menu

Vyvanse

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Lisdexamfetaminelisdexamfetamine dimesylate
lisdexamfetamine dimesylate 30 MG Oral Capsule [Vyvanse]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
175 Lisdexamfetamine Dimesylate (Vyvanse) for the Treatment of Neurogenic Anejaculation
2012
2012
Why would anyone switch to Vyvanse
  • Tni
  • 2012
  • Corpus ID: 180484743
Review
2010
Review
2010
Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder.
Attention-deficit/hyperactivity disorder (ADHD) is a neuropsychiatric condition that affects both children and adults. In a… 
2008
2008
Lisdexamfetamine dimesylate (vyvanse)
2008
2008
Undertreated Pain Can Spark Pseudoaddiction
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)